Glimiyes PG 2mg/500mg/15mg Tablet SR
Marketer
Pharvax Biosciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimiyes PG 2mg/500mg/15mg Tablet SR
Combiflor PG 2mg/500mg/15mg sustained-release tablets manage blood glucose in adults with type 2 diabetes. This medication, used alongside diet and exercise, enhances insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take it with food to prevent gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling up. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor before use if you have kidney, liver, or heart issues, are pregnant, breastfeeding, or anticipate pregnancy. Kidney function tests are typically conducted before treatment commences. Limit alcohol consumption, as it can heighten the risk of adverse effects.
Uses of Glimiyes PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimiyes PG 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Glimiyes PG 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.
Common Side effects of Glimiyes PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimiyes PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiyes PG 2mg/500mg/15mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.
How Glimiyes PG 2mg/500mg/15mg Tablet SR works:
Glimiyes PG 2mg/500mg/15mg extended-release tablets combine the antidiabetic actions of glimepiride, metformin, and pioglitazone. This triple-drug approach offers enhanced blood sugar management when monotherapy or dual-drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimiyes PG 2mg/500mg/15mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiyes PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glimiyes PG 2mg/500mg/15mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimiyes PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Glimiyes PG 2mg/500mg/15mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimiyes PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimiyes PG 2mg/500mg/15mg Tablet SR :
Should you forget to take a Glimiyes PG 2mg/500mg/15mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimiyes PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently